Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
SUSPENDED
NA
1200 participants
INTERVENTIONAL
2025-08-01
2026-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of an Online Program to Help Parents Talk With Their Tween Children About Health, Gender, Body-Image, and Relationships
NCT06408818
Improving Family Well-Being and Child School Readiness: Power PATH Dual Generation Intervention
NCT02176590
Promoting Resilience and Lowering Risk in Early Childhood
NCT05479734
Internet-based Universal Parent Training as a Booster to PATHS®: Parent Web
NCT05172297
Preventing Child Maltreatment Through A Cellular-Phone Technology-Based Parenting Program
NCT01294475
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ColorBRAVE
The experimental group will be asked to download a multi-module mobile app designed to guide parents and caregivers in having conversations about race with their K-2nd grade children
ColorBRAVE
The intervention is a multi-module program delivered via a mobile app for parents of children in K-2nd grade. Each module in the program will take approximately 30 minutes to complete, with lessons facilitated through interactive storytelling, videos, and games.
Wait-list Control
The wait-list control group will be placed on the wait-list for the first 6-weeks, the period in which the experimental group will complete the intervention program. Following the 6-week wait-list period they will receive the ColorBRAVE program.
ColorBRAVE
The intervention is a multi-module program delivered via a mobile app for parents of children in K-2nd grade. Each module in the program will take approximately 30 minutes to complete, with lessons facilitated through interactive storytelling, videos, and games.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ColorBRAVE
The intervention is a multi-module program delivered via a mobile app for parents of children in K-2nd grade. Each module in the program will take approximately 30 minutes to complete, with lessons facilitated through interactive storytelling, videos, and games.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
5 Years
100 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tufts University
OTHER
University of Chicago
OTHER
University of Illinois at Chicago
OTHER
San Diego State University
OTHER
Tulane University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David H. Chae, ScD, MA
Role: PRINCIPAL_INVESTIGATOR
Tulane University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tulane University
New Orleans, Louisiana, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.